Scopolamine-Induced Cognitive Impairment Model
Corresponding Organization : Institute of Bioorganic Chemistry
Other organizations : A.E. Arbuzov Institute of Organic and Physical Chemistry, Ministry of Health of the Russian Federation
Variable analysis
- Administration of scopolamine, an antagonist of muscarinic acetylcholine receptors
- Temporary blockade of receptors
- Impaired cognitive functions
- Impaired cerebral metabolism
- Dose of scopolamine (1.5 mg/kg/5 mL)
- Time of administration (30 min before testing of the passive avoidance reflex)
- Positive control: Not mentioned
- Negative control: Not mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!